Navigation Links
Study reveals rats show regret, a cognitive behavior once thought to be uniquely human
Date:6/8/2014

ented the missed opportunity. Interestingly, the rat's orbitofrontal cortex represented what the rat should have done, not the missed reward. This makes sense because you don't regret the thing you didn't get, you regret the thing you didn't do," said Redish.

Redish adds that results from Restaurant Row allow neuroscientists to ask additional questions to better understand why humans do things the way they do. By building upon this animal model of regret, Redish believes future research could help us understand how regret affects the decisions we make.


'/>"/>

Contact: Matt DePoint
mdepoint@umn.edu
612-625-4110
University of Minnesota Academic Health Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. Law that regulates shark fishery is too liberal: UBC study
3. New study will help protect vulnerable birds from impacts of climate change
4. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
5. BYU study: Using a gun in bear encounters doesnt make you safer
6. 15-year study: When it comes to creating wetlands, Mother Nature is in charge
7. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
8. Crystal structure of archael chromatin clarified in new study
9. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
10. University of Houston study shows BP oil spill hurt marshes, but recovery possible
11. Study demonstrates cells can acquire new functions through transcriptional regulatory network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... marijuana, new research, involving mice and published in the ... Leukocyte Biology , suggests that just because you ... because a team of Italian scientists have found that ... to the immune system. This damage may result in ... sclerosis, inflammatory bowel disease and rheumatoid arthritis in adulthood. ...
(Date:9/30/2014)... 2014  Spectra Automation, a trusted supplier ... and power generation industries, announced today the ... an easy-to-use and cost-effective data collection, analysis ... laboratories. Most upstream process ... systems. Accessing and consolidating data from these ...
(Date:9/29/2014)... the exposure to tar tended to be lower for ... Similarly, exposure to nicotine tended to be lower. , ... in several countries around the world. Previous studies have ... the smoke of these cigarettes are lower than those ... in the smoke are not necessarily linked to a ...
Breaking Biology News(10 mins):Adolescent exposure to thc may cause immune systems to go up in smoke 2Spectra Automation Introduces RECONN Bioprocess Manager 2Slim cigarette smokers not exposed to more harmful chemicals 2
... resistant to Crown Rot a disease that costs Australian ... year. Crown Rot, which is a chronic problem throughout ... Fusarium . Dr Chunji Liu and his CSIRO Plant ... scan over 2400 wheat lines and 1000 barley lines from ...
... 27, 2009 -- Worldwide demand for a safe and ... the forefront of sustainability discussions; however many research programs ... of traditional public or formula grants. Researchers are now ... and international plant breeding programs. Stakeholders from public ...
... Oregon State University researchers shows that those in poverty in ... be eating, but face tough choices between eating well and ... Rosenberger, both professors of anthropology at OSU, examined the "double ... interviews with 76 low-income households in two rural Benton County ...
Cached Biology News:How do we fund plant breeding? 2How do we fund plant breeding? 3Poor in rural Oregon face 'double binds' when getting food 2Poor in rural Oregon face 'double binds' when getting food 3
(Date:9/30/2014)... Sept. 30, 2014 Report Details ... highest potential revenues Do you want to find ... you revenue predictions for those biological drugs from ... you find financial data, R&D trends, opportunities and ... sales forecasts to 2024 at overall world market, ...
(Date:9/30/2014)... 2014 Proove Biosciences , the ... to announce a new genetic test built upon research ... Perception Test will provide physicians with an objective ... tolerance levels are stratified between individuals. With this new ... person has a genetic predisposition that will affect their ...
(Date:9/30/2014)... , September 30, 2014 ... intuitive browsing of chemistry in documents ... software solutions and consulting services for life science ... information and generate Markush structures from documents. ... organizations intellectual property, however generating and understanding Markush ...
(Date:9/30/2014)... Sept. 30, 2014 BioHealth Innovation, Inc. ... market-relevant biohealth innovations and increasing access to early-stage funding ... that venture capitalist, Tania Fernandez , Ph.D., has ... Fernandez will be a member of the management team ... up to $50 million in seed and early-stage equity ...
Breaking Biology Technology:Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2
... Group,plc (AIM: PRG) announces the appointment of Melissa ... will be,responsible for leading the International Business Development ... business development position within,Kendle International leading a Global ... within business development in the CRO sector with ...
... Quigley,Corporation (Nasdaq: QGLY ) today issued an update ... Peripheral Neuropathy by its wholly owned,subsidiary, Quigley Pharma, ... that over 100 subjects have been,enrolled, 52 subjects have ... the Phase IIB study designed to evaluate the safety ...
... Will Begin Promotion in October At U.S. Psychiatric ... Pharmaceuticals,Inc. announced today that it has acquired the ... from Shire,plc. EQUETRO(R) is a treatment for ... Disorder -- a condition where patients experience,extended periods ...
Cached Biology Technology:Premier Research Appoints Melissa Jones as Vice President, International Business Development 2Quigley Corporation Releases Update on Quigley Pharma's Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy 2Quigley Corporation Releases Update on Quigley Pharma's Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy 3Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R) 2
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
Goat polyclonal to HA1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: TLGSCRERQPEFV from the C terminus of human HA1. Entrez GeneID: 23526 Swiss Protein ID: O78181...
Mouse monoclonal [X223] to Lamin B1 + B2 - Nuclear Envelope Marker ( Abpromise for all tested applications). entrezGeneID: 4001 SwissProtID: P20700...
Rabbit polyclonal to XPC ( Abpromise for all tested applications). Antigen: Synthetic peptide from N-terminus of Human XPC conjugated to a carrier protein Entrez Gene ID: 7508 Swiss ...
Biology Products: